Valion Bio VBIO
NASDAQ VBIO
$2.51 -0.29 (-10.36%)
At close: Oct 1, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Interest Expenses (2021 - 2026)

Updated

Valion Bio (VBIO) recorded Interest Expenses of $691,000 in Q2 2026.

Analysis

Valion Bio (VBIO) Interest Expenses (2021 - 2026) Analysis & Trends

On a TTM basis, Valion Bio's Interest Expenses came in at $1.19 million as of Jun 30, 2026; for FY2025, it was $146,000.

  • The Q2 2026 figure is the lowest quarterly Interest Expenses since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Valion Bio 378,559.99 -19.06 Mn - 691,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 691,000.00
Jun 30, 2021 223,000.00
Mar 31, 2021 274,000.00
API Access

Valion Bio Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=VBIO&period=max&api_key=YOUR_API_KEY